These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35793620)

  • 21. Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified.
    Camposano SE; Greenberg E; Kwiatkowski DJ; Thiele EA
    Ann Hum Genet; 2009 Mar; 73(2):141-6. PubMed ID: 19133941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis.
    Rosset C; Vairo F; Bandeira IC; Correia RL; de Goes FV; da Silva RTB; Bueno LSM; de Miranda Gomes MCS; Galvão HCR; Neri JICF; Achatz MI; Netto CBO; Ashton-Prolla P
    PLoS One; 2017; 12(10):e0185713. PubMed ID: 28968464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterisation of the TSC1-TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex.
    Nellist M; Sancak O; Goedbloed M; Adriaans A; Wessels M; Maat-Kievit A; Baars M; Dommering C; van den Ouweland A; Halley D
    BMC Med Genet; 2008 Feb; 9():10. PubMed ID: 18302728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of human induced pluripotent stem cell lines, KMUGMCi006, from a patient with Tuberous sclerosis complex (TSC) bearing mosaic nonsense mutations in the Tuberous sclerosis complex 2 (TSC2) gene.
    Ura H; Togi S; Ozaki M; Hatanaka H; Niida Y
    Stem Cell Res; 2023 Aug; 70():103129. PubMed ID: 37271041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.
    Jones AC; Shyamsundar MM; Thomas MW; Maynard J; Idziaszczyk S; Tomkins S; Sampson JR; Cheadle JP
    Am J Hum Genet; 1999 May; 64(5):1305-15. PubMed ID: 10205261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bama miniature pig model of monoallelic TSC1 mutation for human tuberous sclerosis complex.
    Li X; Hu T; Liu J; Fang B; Geng X; Xiong Q; Zhang L; Jin Y; Liu X; Li L; Wang Y; Li R; Bai X; Yang H; Dai Y
    J Genet Genomics; 2020 Dec; 47(12):735-742. PubMed ID: 33612456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.
    Santiago Lima AJ; Hoogeveen-Westerveld M; Nakashima A; Maat-Kievit A; van den Ouweland A; Halley D; Kikkawa U; Nellist M
    PLoS One; 2014; 9(4):e93940. PubMed ID: 24714658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond.
    Henske EP
    Pediatr Nephrol; 2005 Jul; 20(7):854-7. PubMed ID: 15856327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants.
    Demir S; Yalçıntepe S; Atlı E; Yalçın Y; İkbal Atlı E; Eker D; Karal Y; Gürkan H
    Balkan Med J; 2021 Nov; 38(6):341-347. PubMed ID: 34860161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberous Sclerosis Complex Kidney Lesion Pathogenesis: A Developmental Perspective.
    Pietrobon A; Stanford WL
    J Am Soc Nephrol; 2023 Jul; 34(7):1135-1149. PubMed ID: 37060140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
    Zech R; Kiontke S; Mueller U; Oeckinghaus A; Kümmel D
    J Biol Chem; 2016 Sep; 291(38):20008-20. PubMed ID: 27493206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Transcriptome and Metabolome in Mice with Principal Cell-Specific Ablation of the Tsc1 Gene: Derangements in Pathways Associated with Cell Metabolism, Growth and Acid Secretion.
    Zahedi K; Barone S; Brooks M; Murray Stewart T; Casero RA; Soleimani M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
    Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
    Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.
    Manzanilla-Romero HH; Weis D; Schnaiter S; Rudnik-Schöneborn S
    Am J Med Genet A; 2021 Dec; 185(12):3851-3858. PubMed ID: 34328706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A defect in protein farnesylation suppresses a loss of Schizosaccharomyces pombe tsc2+, a homolog of the human gene predisposing to tuberous sclerosis complex.
    Nakase Y; Fukuda K; Chikashige Y; Tsutsumi C; Morita D; Kawamoto S; Ohnuki M; Hiraoka Y; Matsumoto T
    Genetics; 2006 Jun; 173(2):569-78. PubMed ID: 16624901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.